Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient Activation”

1,177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,177 results

Testing effectiveness (Phase 2)Ended earlyNCT02465957
What this trial is testing

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Who this might be right for
Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
ImmunityBio, Inc. 7
Not applicableUnknownNCT00808600
What this trial is testing

Empowerment of Lung and Heart-lung Transplant Patients

Who this might be right for
Lung TransplantationHeart-Lung Transplantation"Rehabilitation"+2 more
Hannover Medical School 132
Not applicableStudy completedNCT02827357
What this trial is testing

Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation

Who this might be right for
Lung Cancer
University Hospital, Toulouse 101
Testing effectiveness (Phase 2)Study completedNCT01260181
What this trial is testing

Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Not applicableWithdrawnNCT02529098
What this trial is testing

Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation

Who this might be right for
Vision Disorders
University Hospital, Toulouse
Not applicableUnknownNCT00456287
What this trial is testing

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome

Who this might be right for
Sleep ApneaCardiovascular Diseases
Sociedad Española de Neumología y Cirugía Torácica 40
Large-scale testing (Phase 3)WithdrawnNCT01733134
What this trial is testing

Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)

Who this might be right for
Acute Heart Failure
Maisel, Alan, M.D.
Testing effectiveness (Phase 2)Study completedNCT03544814
What this trial is testing

EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression

Who this might be right for
Lung AdenocarcinomaEGFR Activating Mutation
Shanghai Chest Hospital 99
Testing effectiveness (Phase 2)Looking for participantsNCT06411821
What this trial is testing

Ulixertinib in People With Histiocytic Neoplasms

Who this might be right for
Histiocytic Neoplasms
Memorial Sloan Kettering Cancer Center 38
Large-scale testing (Phase 3)Study completedNCT02379845
What this trial is testing

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Who this might be right for
Adult Soft Tissue Sarcoma
Nanobiotix 180
Post-approval studies (Phase 4)Study completedNCT00568893
What this trial is testing

An Open Label Study of Severe Sepsis in Adults

Who this might be right for
Severe Sepsis
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Ended earlyNCT00881439
What this trial is testing

Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment

Who this might be right for
Heart FailureKidney Failure
University Medical Center Groningen 41
Not applicableEnded earlyNCT02483416
What this trial is testing

Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Not applicableNot Yet RecruitingNCT06432387
What this trial is testing

Coagulation Factors Alterations in Patients Undergoing Complex Thoraco-abdominal Aortic Aneurysm Repair

Who this might be right for
Thoraco-abdominal Aortic Aneurysm RepairCoagulation Factors AlterationsPlatelet Activation
University of Thessaly 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091136
What this trial is testing

Exploration of Manidipine to Reverse Aortic Valve Calcification

Who this might be right for
Calcific Aortic Valve Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100
Not applicableLooking for participantsNCT06131775
What this trial is testing

Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer

Who this might be right for
All Types of Solid Cancer
Hospices Civils de Lyon 300
Testing effectiveness (Phase 2)UnknownNCT03844763
What this trial is testing

Targeting the Tumor Microenvironment in R/M SCCHN

Who this might be right for
Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 71
Load More Results